24.66USD+4.14%Mkt Cap: 3.12B USDP/E: —Last update: 2026-05-26
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia P…
Industry Peers
Health Information ServicesIndicators:|
Key Statistics
Company
Market Cap3.12B USD
Enterprise Value2.67B USD
Revenue (TTM)638.78M USD
Gross Profit443.88M USD
Net Income (TTM)-43.54M USD
Revenue/Share5.063 USD
Last Price24.66 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.2K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISINUS88025U1097
Valuation
P/E (Trailing)—
P/E (Forward)123.40
PEG—
EV/EBITDA-87.22
EV/Revenue4.19
P/S4.91
P/B3.96
EPS (TTM)-0.17
EPS (Forward)0.20
52W Range
8.06590% of range26.45
52W High26.45 USD
52W Low8.065 USD
Profitability
Gross Margin69.05%
Oper. Margin-11.30%
EBITDA Margin-4.80%
Profit Margin-6.77%
ROE-5.47%
ROA-4.18%
Growth
Revenue Growth-2.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF136.05M USD
CapEx (TTM)5.93M USD
FCF Margin19.50%
FCF Yield3.99%
Net Debt-458.46M USD
Net Debt/EBITDA14.95
Balance Sheet
Debt/Equity0.11
Current Ratio5.90
Quick Ratio5.25
Book Value/Sh6.236 USD
Cash/Share4.252 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.3 (Buy)
Target (Mean)25.23 USD
Target Range20.00 USD – 32.00 USD
# Analysts13
Ownership
Shares Out.116.88M
Float115.09M
Insiders1.67%
Institutions110.51%
Short Interest
Short Ratio6.6d
Short % Float19.00%
Short % Out.12.80%
Shares Short16.25M
Short (prev mo.)16.02M
Technical
SMA 5021.60 (+14.2%)
SMA 20017.55 (+40.5%)
Beta2.05
S&P 52W Chg28.31%
Avg Vol (30d)2.76M
Avg Vol (10d)3.00M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—